Management of hepatoma using cisplatin/epinephrine gel in patients awaiting orthotopic liver transplantation.
Thuluvath
P J
PJ
Johns Hopkins University, Baltimore, Maryland, USA.
Geschwind
J F
JF
Johnson
P J
PJ
Heneghan
M A
MA
O'Grady
J
J
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage* / Q000009:adverse effects; D004338:Drug Combinations; D004837:Epinephrine / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D005782:Gels; D006801:Humans; D015552:Injections, Intralesional; D008113:Liver Neoplasms / Q000188:drug therapy*; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D016019:Survival Analysis
D000970:Antineoplastic Agents; D004338:Drug Combinations; D005782:Gels; D002945:Cisplatin; D004837:Epinephrine